Description IGF-1 LR3 (Long [Arg] Insulin-like Growth Factor-1) is a recombinant synthetic analog of human insulin-like growth factor 1, engineered with two structural modifications: an arginine substitution replacing glutamate at position 3 of the IGF-1 sequence (reducing IGFBP-3 binding affinity), and a 13-amino-acid N-terminal extension (Long peptide leader)
Since appetite suppression is strongest in days two through five, that is when structuring what you eat around protein and nutrient density matters most
Research & Development (R&D) This initial stage involves discovering and developing GLP-1 peptide molecules with the potential for effective weight loss
Requires laboratory testing prior to administration
It functions by blocking an enzyme responsible for cellular aging and fat storage, thereby promoting improved energy metabolism, efficient fat management, and cellular rejuvenation, which can particularly benefit skin health
Polley pointed out that even patients with similar clinical profiles might prioritize different aspects of their health or quality of life